Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 359

    1.

    Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.

    Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald PJ; RESOLUTE Investigators.

    JACC Cardiovasc Interv. 2009 Oct;2(10):977-85.PMID: 19850258 [PubMed - in process]Related articles

    2.

    Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

    Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB.

    JACC Cardiovasc Interv. 2009 Oct;2(10):967-76.PMID: 19850257 [PubMed - in process]Related articles

    3.

    Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

    Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA; American College of Cardiology Interventional Scientific Council.

    J Am Coll Cardiol. 2009 Oct 20;54(17):1576-88.PMID: 19833256 [PubMed - indexed for MEDLINE]Related articles

    4.

    "Bailing out" side branches: technique trumps technology, round 1.

    Yang X, Popma JJ.

    J Invasive Cardiol. 2009 Oct;21(10):538. No abstract available. PMID: 19805842 [PubMed - in process]Related articlesFree article

    5.

    Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.

    George JC, Popma JJ.

    JACC Cardiovasc Interv. 2009 Sep;2(9):894-6. No abstract available. PMID: 19778781 [PubMed - in process]Related articles

    6.

    Rebuttal: Reply to the letter to the editor by Dr. Hirsh.

    Tommaso CL, Dehmer GJ, Babb JD, Weiner BH, Chambers CE, Cox DA, Harrington RA, Popma JJ, Turco MA.

    Catheter Cardiovasc Interv. 2009 Jul 15. [Epub ahead of print] No abstract available. PMID: 19739263 [PubMed - as supplied by publisher]Related articles

    7.

    The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction.

    Friedewald VE, Gibbons RJ, O'Neill WW, Popma JJ, Stone GW, Roberts WC.

    Am J Cardiol. 2009 Sep 15;104(6):791-7. No abstract available. PMID: 19733713 [PubMed - indexed for MEDLINE]Related articles

    8.

    5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

    J Am Coll Cardiol. 2009 Sep 1;54(10):894-902.PMID: 19712798 [PubMed - indexed for MEDLINE]Related articles

    9.

    JACC White Papers: an avenue for interventional knowledge?

    Dangas GD, Popma JJ; ACC Interventional Scientific Council.

    JACC Cardiovasc Interv. 2009 May;2(5):472-3. No abstract available. PMID: 19463474 [PubMed - in process]Related articles

    10.

    TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.

    Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ, O'Shaughnessy CD, Mann T, Hall JJ, McGarry TF, Cannon LA, Webster MW, Mandinov L, Baim DS.

    JACC Cardiovasc Interv. 2009 Mar;2(3):240-52.PMID: 19463432 [PubMed - in process]Related articles

    11.

    Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.

    Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS.

    JACC Cardiovasc Interv. 2008 Dec;1(6):699-709.PMID: 19463387 [PubMed - indexed for MEDLINE]Related articles

    12.

    A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.

    Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB; ZoMaxx I Investigators.

    JACC Cardiovasc Interv. 2008 Oct;1(5):524-32.PMID: 19463354 [PubMed - indexed for MEDLINE]Related articles

    13.

    Structure and function of the ACC Interventional Scientific Council and Section.

    Popma JJ, Dangas GD, Tommaso CL, Bailes SC.

    JACC Cardiovasc Interv. 2008 Aug;1(4):452-5. No abstract available. PMID: 19463344 [PubMed - indexed for MEDLINE]Related articles

    14.

    3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.

    Holmes DR Jr, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA; SISR Investigators.

    JACC Cardiovasc Interv. 2008 Aug;1(4):439-48.PMID: 19463342 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recertification in interventional cardiology.

    Dangas GD, Popma JJ.

    JACC Cardiovasc Interv. 2008 Jun;1(3):332-4. No abstract available. PMID: 19463325 [PubMed - indexed for MEDLINE]Related articles

    16.

    A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.

    Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE; AMEthyst Study Investigators.

    JACC Cardiovasc Interv. 2008 Jun;1(3):248-57.PMID: 19463308 [PubMed - indexed for MEDLINE]Related articles

    17.

    Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.

    Ormiston JA, Mahmud E, Turco MA, Popma JJ, Weissman N, Cannon LA, Mann T, Lucca MJ, Lim ST, Hall JJ, McClean D, Dobies D, Mandinov L, Baim DS.

    JACC Cardiovasc Interv. 2008 Apr;1(2):150-60.PMID: 19463293 [PubMed - indexed for MEDLINE]Related articles

    18.

    Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation.

    Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL; Society for Cardiovascular Angiography and Interventions.

    Catheter Cardiovasc Interv. 2009 Jun 1;73(7):847-58. Review.PMID: 19425053 [PubMed - indexed for MEDLINE]Related articles

    19.

    Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

    Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW.

    J Am Coll Cardiol. 2009 Apr 28;53(17):1488-97.PMID: 19389558 [PubMed - indexed for MEDLINE]Related articles

    20.

    A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.

    Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB.

    Am J Cardiol. 2009 Apr 1;103(7):923-9.PMID: 19327417 [PubMed - indexed for MEDLINE]Related articles

    21.

    An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents.

    Liu J, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW.

    Am J Cardiol. 2009 Feb 15;103(4):501-6. Epub 2008 Dec 25.PMID: 19195510 [PubMed - indexed for MEDLINE]Related articles

    22.

    Conclusion: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy.

    Popma JJ.

    J Invasive Cardiol. 2008 Aug;20(8 Suppl A):25A. No abstract available. PMID: 18830020 [PubMed - indexed for MEDLINE]Related articles

    23.

    Introduction: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy.

    Popma JJ.

    J Invasive Cardiol. 2008 Aug;20(8 Suppl A):1A. No abstract available. PMID: 18830013 [PubMed - indexed for MEDLINE]Related articles

    24.

    High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions.

    Tiroch K, Cannon L, Reisman M, Caputo R, Caulfield T, Heuser R, Braden G, Low R, Stone G, Almonacid A, Popma JJ.

    Catheter Cardiovasc Interv. 2008 Nov 15;72(6):771-80.PMID: 19006244 [PubMed - indexed for MEDLINE]Related articles

    25.

    Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG; American College of Chest Physicians.

    Chest. 2008 Jun;133(6 Suppl):670S-707S.PMID: 18574276 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.

    Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW; TAXUS V ISR Investigators.

    Eur Heart J. 2008 Jul;29(13):1625-34. Epub 2008 Jun 13.PMID: 18556716 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity.

    Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, Dorbala S, Popma JJ, Di Carli MF.

    Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1593-601. Epub 2008 Apr 19.PMID: 18425513 [PubMed - indexed for MEDLINE]Related articles

    28.

    Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.

    Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW.

    J Am Coll Cardiol. 2008 Feb 19;51(7):708-15.PMID: 18279734 [PubMed - indexed for MEDLINE]Related articles

    29.

    Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.

    Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L.

    Circulation. 2008 Feb 12;117(6):790-7. Epub 2008 Jan 22.PMID: 18212287 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.

    Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW.

    J Am Coll Cardiol. 2008 Jan 1;51(1):23-32.PMID: 18174032 [PubMed - indexed for MEDLINE]Related articles

    31.

    Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.

    Abizaid A, Popma JJ, Tanajura LF, Hattori K, Solberg B, Larracas C, Feres F, Costa Jde R Jr, Schwartz LB.

    Catheter Cardiovasc Interv. 2007 Dec 1;70(7):914-9.PMID: 18044791 [PubMed - indexed for MEDLINE]Related articles

    32.

    FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.

    Popma JJ, Weiner B, Cowley MJ, Simonton C, McCormick D, Feldman T.

    J Interv Cardiol. 2007 Dec;20(6):425-46. Review. No abstract available. PMID: 18042048 [PubMed - indexed for MEDLINE]Related articles

    33.

    Gender-specific outcomes after sirolimus-eluting stent implantation.

    Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R.

    J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6. Epub 2007 Nov 13.PMID: 18036446 [PubMed - indexed for MEDLINE]Related articles

    34.

    Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.

    Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Popma JJ, Cutlip DE, Fitzgerald PJ; ENDEAVOR I Investigators.

    Am J Cardiol. 2007 Oct 22;100(8B):56M-61M.PMID: 17950833 [PubMed - indexed for MEDLINE]Related articles

    35.

    Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.

    Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J, Popma JJ, Fitzgerald PJ, Kuntz RE; ENDEAVOR Investigators.

    Am J Cardiol. 2007 Oct 22;100(8B):45M-55M. Review.PMID: 17950832 [PubMed - indexed for MEDLINE]Related articles

    36.

    TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.

    Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russell ME.

    Eur Heart J. 2007 Nov;28(21):2578-82. Epub 2007 Oct 14.PMID: 17938126 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    The truth and consequences of the COURAGE trial.

    Kereiakes DJ, Teirstein PS, Sarembock IJ, Holmes DR Jr, Krucoff MW, O'Neill WW, Waksman R, Williams DO, Popma JJ, Buchbinder M, Mehran R, Meredith IT, Moses JW, Stone GW.

    J Am Coll Cardiol. 2007 Oct 16;50(16):1598-603. Epub 2007 Sep 17.PMID: 17936161 [PubMed - indexed for MEDLINE]Related articles

    38.

    The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.

    Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C.

    J Am Coll Cardiol. 2007 Oct 9;50(15):1442-9. Epub 2007 Sep 24.PMID: 17919563 [PubMed - indexed for MEDLINE]Related articles

    39.

    The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.

    Moses JW, Weisz G, Mishkel G, Caputo R, O'shaughnessey C, Wong SC, Fischell TA, Mooney M, Williams DO, Popma JJ, Fitzgerald P, Smith S, Kuntz RE, Collins M, Cohen SA, Leon MB.

    Catheter Cardiovasc Interv. 2007 Oct 1;70(4):505-12.PMID: 17896408 [PubMed - indexed for MEDLINE]Related articles

    40.

    Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).

    Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ; ENDEAVOR II Trial Investigators.

    Am J Cardiol. 2007 Sep 1;100(5):818-23. Epub 2007 Jun 14.PMID: 17719326 [PubMed - indexed for MEDLINE]Related articles

    41.

    Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.

    Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Weissman NJ, Koglin J, Russell ME.

    EuroIntervention. 2007 Aug;3(2):213-21.PMID: 19758940 [PubMed - in process]Related articles

    42.

    Thrombosis and drug-eluting stents: an objective appraisal.

    Holmes DR Jr, Kereiakes DJ, Laskey WK, Colombo A, Ellis SG, Henry TD, Popma JJ, Serruys PW, Kimura T, Williams DO, Windecker S, Krucoff MW.

    J Am Coll Cardiol. 2007 Jul 10;50(2):109-18. Epub 2007 May 22. Review.PMID: 17616294 [PubMed - indexed for MEDLINE]Related articles

    43.

    Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry.

    Schultheiss HP, Grube E, Kuck KH, Suttorp MJ, Heuer H, Bonnier H, Popma JJ, Kuntz RE, Fajadet J, Wijns W.

    EuroIntervention. 2007 May;3(1):76-81.PMID: 19737688 [PubMed - in process]Related articles

    44.

    Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.

    Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J.

    J Am Coll Cardiol. 2007 Apr 24;49(16):1676-83. Epub 2007 Apr 6.PMID: 17448368 [PubMed - indexed for MEDLINE]Related articles

    45.

    Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).

    Weisz G, Moses JW, Teirstein PS, Holmes DR Jr, Raizner AE, Satler LF, Mishkel G, Wilensky RL, Wang P, Kuntz RE, Popma JJ, Leon MB.

    Am J Cardiol. 2007 Apr 15;99(8):1044-50. Epub 2007 Feb 26.PMID: 17437725 [PubMed - indexed for MEDLINE]Related articles

    46.

    Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study.

    Stone PH, Coskun AU, Kinlay S, Popma JJ, Sonka M, Wahle A, Yeghiazarians Y, Maynard C, Kuntz RE, Feldman CL.

    Eur Heart J. 2007 Mar;28(6):705-10. Epub 2007 Mar 8.PMID: 17347172 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.

    Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators.

    Minerva Cardioangiol. 2007 Feb;55(1):1-18. English, Italian. PMID: 17287679 [PubMed - indexed for MEDLINE]Related articles

    48.

    The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.

    Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W.

    Circulation. 2006 Dec 19;114(25):2871-91. Review. No abstract available. PMID: 17179035 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

    Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W.

    Circulation. 2006 Dec 19;114(25):2850-70. Review. No abstract available. PMID: 17179034 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

    Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE; ENDEAVOR III Investigators.

    J Am Coll Cardiol. 2006 Dec 19;48(12):2440-7. Epub 2006 Nov 28.PMID: 17174180 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...